Patterns of Treatment Failure After Selective Rearranged During Transfection (RET) Inhibitors in Patients With Metastatic Medullary Thyroid Carcinoma.
Julien HadouxAbir Al GhuzlanLivia LamartinaMohamed Amine BaniSophie MoogMarie AttardJean Yves ScoazecDana M HartlMihaela AldeaLuc FribouletGerome Jules-ClementAntoine ItalianoBenjamin BesseLudovic LacroixEric BaudinPublished in: JCO precision oncology (2023)
Bypass resistance may be the most frequent mechanism of progression under RETi. A more aggressive histology may arise following RETi and warrants further investigation.
Keyphrases